A Mold-Like Organism in Urine Sediment
Clin Chem. 2026 Feb 3;72(2):321-322. doi: 10.1093/clinchem/hvaf138. NO ABSTRACT PMID:41631817 | DOI:10.1093/clinchem/hvaf138
Journal
Triglyceride Turmoil: Unraveling a Complex Case
Clin Chem. 2026 Feb 3;72(2):232-235. doi: 10.1093/clinchem/hvaf103. NO ABSTRACT PMID:41631816 | DOI:10.1093/clinchem/hvaf103
Commentary on Triglyceride Turmoil: Unraveling a Complex Case
Clin Chem. 2026 Feb 3;72(2):236-237. doi: 10.1093/clinchem/hvaf128. NO ABSTRACT PMID:41631815 | DOI:10.1093/clinchem/hvaf128
Metabolomic Signatures of Ultra-Processed Food Intake: Toward Objective Dietary Biomarkers
Clin Chem. 2026 Feb 3;72(2):323-324. doi: 10.1093/clinchem/hvaf129. NO ABSTRACT PMID:41631814 | DOI:10.1093/clinchem/hvaf129
Commentary on Triglyceride Turmoil: Unravelling a Complex Case
Clin Chem. 2026 Feb 3;72(2):235-236. doi: 10.1093/clinchem/hvaf127. NO ABSTRACT PMID:41631813 | DOI:10.1093/clinchem/hvaf127
Detection of Advanced Liver Fibrosis Using Blood Noninvasive Tests: A Laboratory Medicine Perspective
Clin Chem. 2026 Feb 3:hvaf193. doi: 10.1093/clinchem/hvaf193. Online ahead of print. ABSTRACT BACKGROUND: Despite its growing impact, advanced liver fibrosis (ALF) remains substantially underdiagnosed in both primary and specialized care settings. Since liver cirrhosis is typically preceded by a prolonged phase of asymptomatic fibrosis, early detection of ALF, particularly in high-risk individuals, represents a public … Read more
Blood biomarkers in neurodegenerative diseases: pre-analytical, analytical, and post-analytical challengesConstance Delabyon February 3, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Feb 3. doi: 10.1515/cclm-2025-1731. Online ahead of print. ABSTRACT Recent advances in blood-based biomarkers for neurodegenerative diseases present promising opportunities for earlier diagnosis and more effective disease monitoring. However, challenges in standardizing sample collection, processing protocols, and data reporting continue to hinder reproducibility, limit cross-study comparability, and delay clinical adoption. … Read more
Green laboratory through test ordering appropriateness and innovationSveva Stangalinion February 3, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Feb 3. doi: 10.1515/cclm-2025-1606. Online ahead of print. ABSTRACT OBJECTIVES: Clinical laboratories play a vital role in healthcare but are also among the most resource-intensive hospital units. High energy and water consumption, extensive use of single-use plastics, and the generation of non-recyclable biomedical waste present major environmental challenges. This study … Read more
Implementation of AI systems in the clinical laboratory: insights from an expert survey and recommendations for best practiceHe S Yangon February 3, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Feb 3. doi: 10.1515/cclm-2025-1322. Online ahead of print. ABSTRACT OBJECTIVES: Despite growing interest in artificial intelligence (AI) and machine learning (ML), many laboratory professionals lack experience with developing in-house AI systems or implementing those supplied by external providers. The IFCC Committee on AI in Laboratory Medicine (C-AILM) conducted a survey … Read more
Antiphosphatidylserine/prothrombin antibodies define a high-risk antiphospholipid syndrome profile associated with organ damageAriela Hoxhaon February 3, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Feb 3. doi: 10.1515/cclm-2025-1565. Online ahead of print. ABSTRACT OBJECTIVES: Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are promising non-criteria aPLs associated with antiphospholipid syndrome (APS) manifestations. Their influence on long-term outcomes and damage remains uncertain. To assess aPS/PT antibodies association with accrual damage and severe APS disease phenotypes, focusing on their potential for … Read more